InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Patrick Lamy, a Senior VP, Commercial Strategy, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $1.3M, reported from Jun 11, 24 to Jul 1, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 25 | AKROAkero Therapeutics, Inc. | SELL | 2.0K | $52.88 | $106K |
| Jun 20, 25 | AKROAkero Therapeutics, Inc. | SELL | 875 | $54.59 | $48K |
| Jun 16, 25 | AKROAkero Therapeutics, Inc. | SELL | 1.5K | $55.09 | $81K |
| Jun 10, 25 | AKROAkero Therapeutics, Inc. | SELL | 919 | $54.00 | $50K |
| Jun 2, 25 | AKROAkero Therapeutics, Inc. | SELL | 3.3K | $51.04 | $167K |
| May 22, 25 | AKROAkero Therapeutics, Inc. | SELL | 4.0K | $50.00 | $200K |
| May 7, 25 | AKROAkero Therapeutics, Inc. | SELL | 4.7K | $42.76 | $199K |
| Mar 3, 25 | AKROAkero Therapeutics, Inc. | SELL | 1.0K | $48.09 | $48K |
| Jan 27, 25 | AKROAkero Therapeutics, Inc. | SELL | 5.0K | $57.03 | $285K |
| Dec 16, 24 | AKROAkero Therapeutics, Inc. | SELL | 1.0K | $29.13 | $29K |
| Dec 10, 24 | AKROAkero Therapeutics, Inc. | SELL | 925 | $30.79 | $28K |
| Jun 11, 24 | AKROAkero Therapeutics, Inc. | SELL | 569 | $22.64 | $13K |